nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Penbutolol—coronary artery disease	0.356	1	CrCtD
Carteolol—ADRB1—coronary artery disease	0.0907	0.543	CbGaD
Carteolol—ADRB2—coronary artery disease	0.0763	0.457	CbGaD
Carteolol—Bupranolol—Gemfibrozil—coronary artery disease	0.0685	0.271	CrCrCtD
Carteolol—ADRB2—Penbutolol—coronary artery disease	0.0354	0.223	CbGbCtD
Carteolol—Levobunolol—Timolol—coronary artery disease	0.0351	0.139	CrCrCtD
Carteolol—ADRB1—Penbutolol—coronary artery disease	0.0349	0.22	CbGbCtD
Carteolol—Penbutolol—Timolol—coronary artery disease	0.0319	0.126	CrCrCtD
Carteolol—Nadolol—Penbutolol—coronary artery disease	0.0298	0.118	CrCrCtD
Carteolol—Levobunolol—Penbutolol—coronary artery disease	0.0298	0.118	CrCrCtD
Carteolol—Bupranolol—Timolol—coronary artery disease	0.0254	0.1	CrCrCtD
Carteolol—ADRB2—Timolol—coronary artery disease	0.025	0.157	CbGbCtD
Carteolol—ADRB1—Timolol—coronary artery disease	0.0246	0.155	CbGbCtD
Carteolol—Bupranolol—Penbutolol—coronary artery disease	0.0216	0.0853	CrCrCtD
Carteolol—Propranolol—Penbutolol—coronary artery disease	0.0106	0.0421	CrCrCtD
Carteolol—CYP2D6—Niacin—coronary artery disease	0.00673	0.0424	CbGbCtD
Carteolol—CYP2D6—Timolol—coronary artery disease	0.00626	0.0394	CbGbCtD
Carteolol—CYP2D6—Captopril—coronary artery disease	0.00551	0.0347	CbGbCtD
Carteolol—CYP2D6—Simvastatin—coronary artery disease	0.00532	0.0335	CbGbCtD
Carteolol—CYP2D6—Pravastatin—coronary artery disease	0.00521	0.0328	CbGbCtD
Carteolol—CYP2D6—Lovastatin—coronary artery disease	0.00521	0.0328	CbGbCtD
Carteolol—CYP2D6—Atorvastatin—coronary artery disease	0.00474	0.0299	CbGbCtD
Carteolol—Levobunolol—ADRB1—coronary artery disease	0.000164	0.101	CrCbGaD
Carteolol—Levobunolol—ADRB2—coronary artery disease	0.000138	0.0854	CrCbGaD
Carteolol—Nadolol—ADRB1—coronary artery disease	0.000124	0.0769	CrCbGaD
Carteolol—Bupranolol—ADRB1—coronary artery disease	0.000119	0.0734	CrCbGaD
Carteolol—Bopindolol—ADRB1—coronary artery disease	0.000114	0.0704	CrCbGaD
Carteolol—Salbutamol—ADRB1—coronary artery disease	0.000112	0.069	CrCbGaD
Carteolol—Penbutolol—ADRB1—coronary artery disease	0.000109	0.0671	CrCbGaD
Carteolol—Nadolol—ADRB2—coronary artery disease	0.000105	0.0647	CrCbGaD
Carteolol—Bupranolol—ADRB2—coronary artery disease	9.99e-05	0.0617	CrCbGaD
Carteolol—Bopindolol—ADRB2—coronary artery disease	9.57e-05	0.0592	CrCbGaD
Carteolol—Salbutamol—ADRB2—coronary artery disease	9.39e-05	0.058	CrCbGaD
Carteolol—Penbutolol—ADRB2—coronary artery disease	9.13e-05	0.0564	CrCbGaD
Carteolol—Shock—Eplerenone—coronary artery disease	8.57e-05	0.00186	CcSEcCtD
Carteolol—Vision blurred—Enalapril—coronary artery disease	8.57e-05	0.00186	CcSEcCtD
Carteolol—Syncope—Niacin—coronary artery disease	8.56e-05	0.00186	CcSEcCtD
Carteolol—Dysgeusia—Captopril—coronary artery disease	8.54e-05	0.00185	CcSEcCtD
Carteolol—Hypotension—Clopidogrel—coronary artery disease	8.53e-05	0.00185	CcSEcCtD
Carteolol—Asthenia—Ticagrelor—coronary artery disease	8.53e-05	0.00185	CcSEcCtD
Carteolol—Depression—Timolol—coronary artery disease	8.49e-05	0.00184	CcSEcCtD
Carteolol—Oedema—Simvastatin—coronary artery disease	8.48e-05	0.00184	CcSEcCtD
Carteolol—Nausea—Penbutolol—coronary artery disease	8.47e-05	0.00184	CcSEcCtD
Carteolol—Conjunctivitis—Ramipril—coronary artery disease	8.47e-05	0.00184	CcSEcCtD
Carteolol—Arrhythmia—Furosemide—coronary artery disease	8.44e-05	0.00183	CcSEcCtD
Carteolol—Palpitations—Niacin—coronary artery disease	8.43e-05	0.00183	CcSEcCtD
Carteolol—Insomnia—Fenofibrate—coronary artery disease	8.4e-05	0.00182	CcSEcCtD
Carteolol—Loss of consciousness—Niacin—coronary artery disease	8.39e-05	0.00182	CcSEcCtD
Carteolol—Dysgeusia—Perindopril—coronary artery disease	8.29e-05	0.0018	CcSEcCtD
Carteolol—Dyspnoea—Fenofibrate—coronary artery disease	8.28e-05	0.00179	CcSEcCtD
Carteolol—Conjunctivitis—Timolol—coronary artery disease	8.28e-05	0.00179	CcSEcCtD
Carteolol—Insomnia—Clopidogrel—coronary artery disease	8.26e-05	0.00179	CcSEcCtD
Carteolol—Vision blurred—Captopril—coronary artery disease	8.21e-05	0.00178	CcSEcCtD
Carteolol—Insomnia—Lovastatin—coronary artery disease	8.2e-05	0.00178	CcSEcCtD
Carteolol—Syncope—Trandolapril—coronary artery disease	8.18e-05	0.00177	CcSEcCtD
Carteolol—Sinusitis—Ramipril—coronary artery disease	8.17e-05	0.00177	CcSEcCtD
Carteolol—Syncope—Enalapril—coronary artery disease	8.15e-05	0.00177	CcSEcCtD
Carteolol—Arrhythmia—Losartan—coronary artery disease	8.15e-05	0.00177	CcSEcCtD
Carteolol—Dyspnoea—Clopidogrel—coronary artery disease	8.14e-05	0.00176	CcSEcCtD
Carteolol—Hypotension—Eplerenone—coronary artery disease	8.13e-05	0.00176	CcSEcCtD
Carteolol—Dyspnoea—Lovastatin—coronary artery disease	8.08e-05	0.00175	CcSEcCtD
Carteolol—Palpitations—Trandolapril—coronary artery disease	8.06e-05	0.00175	CcSEcCtD
Carteolol—Dysgeusia—Furosemide—coronary artery disease	8.06e-05	0.00175	CcSEcCtD
Carteolol—Dizziness—Gemfibrozil—coronary artery disease	8.05e-05	0.00174	CcSEcCtD
Carteolol—Insomnia—Ezetimibe—coronary artery disease	8.04e-05	0.00174	CcSEcCtD
Carteolol—Syncope—Telmisartan—coronary artery disease	8.04e-05	0.00174	CcSEcCtD
Carteolol—Palpitations—Enalapril—coronary artery disease	8.03e-05	0.00174	CcSEcCtD
Carteolol—Loss of consciousness—Trandolapril—coronary artery disease	8.02e-05	0.00174	CcSEcCtD
Carteolol—Oedema—Valsartan—coronary artery disease	8.01e-05	0.00174	CcSEcCtD
Carteolol—Sinusitis—Timolol—coronary artery disease	7.99e-05	0.00173	CcSEcCtD
Carteolol—Loss of consciousness—Enalapril—coronary artery disease	7.99e-05	0.00173	CcSEcCtD
Carteolol—Oedema—Olmesartan—coronary artery disease	7.97e-05	0.00173	CcSEcCtD
Carteolol—Dyspnoea—Ezetimibe—coronary artery disease	7.93e-05	0.00172	CcSEcCtD
Carteolol—Palpitations—Telmisartan—coronary artery disease	7.92e-05	0.00172	CcSEcCtD
Carteolol—Hypersensitivity—Rosuvastatin—coronary artery disease	7.88e-05	0.00171	CcSEcCtD
Carteolol—Shock—Valsartan—coronary artery disease	7.88e-05	0.00171	CcSEcCtD
Carteolol—Loss of consciousness—Telmisartan—coronary artery disease	7.88e-05	0.00171	CcSEcCtD
Carteolol—Depression—Lisinopril—coronary artery disease	7.88e-05	0.00171	CcSEcCtD
Carteolol—Insomnia—Eplerenone—coronary artery disease	7.87e-05	0.00171	CcSEcCtD
Carteolol—Dizziness—Ticagrelor—coronary artery disease	7.86e-05	0.0017	CcSEcCtD
Carteolol—Shock—Olmesartan—coronary artery disease	7.84e-05	0.0017	CcSEcCtD
Carteolol—Pindolol—ADRB1—coronary artery disease	7.83e-05	0.0484	CrCbGaD
Carteolol—Syncope—Captopril—coronary artery disease	7.82e-05	0.00169	CcSEcCtD
Carteolol—Oedema—Niacin—coronary artery disease	7.79e-05	0.00169	CcSEcCtD
Carteolol—Bradycardia—Timolol—coronary artery disease	7.78e-05	0.00169	CcSEcCtD
Carteolol—Dysgeusia—Losartan—coronary artery disease	7.77e-05	0.00169	CcSEcCtD
Carteolol—Dyspnoea—Eplerenone—coronary artery disease	7.76e-05	0.00168	CcSEcCtD
Carteolol—Vision blurred—Furosemide—coronary artery disease	7.75e-05	0.00168	CcSEcCtD
Carteolol—Palpitations—Captopril—coronary artery disease	7.7e-05	0.00167	CcSEcCtD
Carteolol—Asthenia—Rosuvastatin—coronary artery disease	7.68e-05	0.00166	CcSEcCtD
Carteolol—Insomnia—Simvastatin—coronary artery disease	7.67e-05	0.00166	CcSEcCtD
Carteolol—Oedema—Pravastatin—coronary artery disease	7.67e-05	0.00166	CcSEcCtD
Carteolol—Shock—Niacin—coronary artery disease	7.66e-05	0.00166	CcSEcCtD
Carteolol—Loss of consciousness—Captopril—coronary artery disease	7.66e-05	0.00166	CcSEcCtD
Carteolol—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	7.66e-05	0.00166	CcSEcCtD
Carteolol—Headache—Gemfibrozil—coronary artery disease	7.62e-05	0.00165	CcSEcCtD
Carteolol—Syncope—Perindopril—coronary artery disease	7.59e-05	0.00165	CcSEcCtD
Carteolol—Dyspnoea—Simvastatin—coronary artery disease	7.56e-05	0.00164	CcSEcCtD
Carteolol—Visual impairment—Ramipril—coronary artery disease	7.54e-05	0.00163	CcSEcCtD
Carteolol—Hypotension—Valsartan—coronary artery disease	7.49e-05	0.00162	CcSEcCtD
Carteolol—Vision blurred—Losartan—coronary artery disease	7.48e-05	0.00162	CcSEcCtD
Carteolol—Palpitations—Perindopril—coronary artery disease	7.48e-05	0.00162	CcSEcCtD
Carteolol—Hypotension—Olmesartan—coronary artery disease	7.45e-05	0.00161	CcSEcCtD
Carteolol—Headache—Ticagrelor—coronary artery disease	7.45e-05	0.00161	CcSEcCtD
Carteolol—Oedema—Trandolapril—coronary artery disease	7.45e-05	0.00161	CcSEcCtD
Carteolol—Loss of consciousness—Perindopril—coronary artery disease	7.44e-05	0.00161	CcSEcCtD
Carteolol—Oedema—Enalapril—coronary artery disease	7.42e-05	0.00161	CcSEcCtD
Carteolol—Sinusitis—Lisinopril—coronary artery disease	7.41e-05	0.00161	CcSEcCtD
Carteolol—Visual impairment—Timolol—coronary artery disease	7.37e-05	0.0016	CcSEcCtD
Carteolol—Shock—Trandolapril—coronary artery disease	7.33e-05	0.00159	CcSEcCtD
Carteolol—Oedema—Telmisartan—coronary artery disease	7.32e-05	0.00159	CcSEcCtD
Carteolol—Shock—Enalapril—coronary artery disease	7.3e-05	0.00158	CcSEcCtD
Carteolol—Hypotension—Niacin—coronary artery disease	7.28e-05	0.00158	CcSEcCtD
Carteolol—Insomnia—Valsartan—coronary artery disease	7.25e-05	0.00157	CcSEcCtD
Carteolol—Nausea—Gemfibrozil—coronary artery disease	7.23e-05	0.00157	CcSEcCtD
Carteolol—Bradycardia—Lisinopril—coronary artery disease	7.22e-05	0.00156	CcSEcCtD
Carteolol—Insomnia—Olmesartan—coronary artery disease	7.21e-05	0.00156	CcSEcCtD
Carteolol—Shock—Telmisartan—coronary artery disease	7.2e-05	0.00156	CcSEcCtD
Carteolol—Dyspnoea—Valsartan—coronary artery disease	7.14e-05	0.00155	CcSEcCtD
Carteolol—Syncope—Losartan—coronary artery disease	7.12e-05	0.00154	CcSEcCtD
Carteolol—Dizziness—Rosuvastatin—coronary artery disease	7.08e-05	0.00153	CcSEcCtD
Carteolol—Nausea—Ticagrelor—coronary artery disease	7.06e-05	0.00153	CcSEcCtD
Carteolol—Insomnia—Niacin—coronary artery disease	7.04e-05	0.00153	CcSEcCtD
Carteolol—Palpitations—Losartan—coronary artery disease	7.01e-05	0.00152	CcSEcCtD
Carteolol—Shock—Captopril—coronary artery disease	7e-05	0.00152	CcSEcCtD
Carteolol—Arrhythmia—Ramipril—coronary artery disease	6.99e-05	0.00151	CcSEcCtD
Carteolol—Loss of consciousness—Losartan—coronary artery disease	6.98e-05	0.00151	CcSEcCtD
Carteolol—Hypotension—Trandolapril—coronary artery disease	6.96e-05	0.00151	CcSEcCtD
Carteolol—Dyspnoea—Niacin—coronary artery disease	6.94e-05	0.00151	CcSEcCtD
Carteolol—Insomnia—Pravastatin—coronary artery disease	6.94e-05	0.0015	CcSEcCtD
Carteolol—Hypotension—Enalapril—coronary artery disease	6.93e-05	0.0015	CcSEcCtD
Carteolol—Oedema—Perindopril—coronary artery disease	6.91e-05	0.0015	CcSEcCtD
Carteolol—Dizziness—Acetylsalicylic acid—coronary artery disease	6.87e-05	0.00149	CcSEcCtD
Carteolol—Hypersensitivity—Fenofibrate—coronary artery disease	6.84e-05	0.00148	CcSEcCtD
Carteolol—Dyspnoea—Pravastatin—coronary artery disease	6.84e-05	0.00148	CcSEcCtD
Carteolol—Hypotension—Telmisartan—coronary artery disease	6.84e-05	0.00148	CcSEcCtD
Carteolol—Arrhythmia—Timolol—coronary artery disease	6.83e-05	0.00148	CcSEcCtD
Carteolol—Shock—Perindopril—coronary artery disease	6.8e-05	0.00147	CcSEcCtD
Carteolol—Insomnia—Trandolapril—coronary artery disease	6.74e-05	0.00146	CcSEcCtD
Carteolol—Hypersensitivity—Clopidogrel—coronary artery disease	6.73e-05	0.00146	CcSEcCtD
Carteolol—Insomnia—Enalapril—coronary artery disease	6.71e-05	0.00145	CcSEcCtD
Carteolol—Headache—Rosuvastatin—coronary artery disease	6.7e-05	0.00145	CcSEcCtD
Carteolol—Hypersensitivity—Lovastatin—coronary artery disease	6.68e-05	0.00145	CcSEcCtD
Carteolol—Dysgeusia—Ramipril—coronary artery disease	6.67e-05	0.00144	CcSEcCtD
Carteolol—Asthenia—Fenofibrate—coronary artery disease	6.66e-05	0.00144	CcSEcCtD
Carteolol—Hypotension—Captopril—coronary artery disease	6.65e-05	0.00144	CcSEcCtD
Carteolol—Dyspnoea—Trandolapril—coronary artery disease	6.64e-05	0.00144	CcSEcCtD
Carteolol—Insomnia—Telmisartan—coronary artery disease	6.62e-05	0.00143	CcSEcCtD
Carteolol—Dyspnoea—Enalapril—coronary artery disease	6.61e-05	0.00143	CcSEcCtD
Carteolol—Shock—Furosemide—coronary artery disease	6.61e-05	0.00143	CcSEcCtD
Carteolol—Pindolol—ADRB2—coronary artery disease	6.58e-05	0.0407	CrCbGaD
Carteolol—Hypersensitivity—Ezetimibe—coronary artery disease	6.55e-05	0.00142	CcSEcCtD
Carteolol—Asthenia—Clopidogrel—coronary artery disease	6.55e-05	0.00142	CcSEcCtD
Carteolol—Dyspnoea—Telmisartan—coronary artery disease	6.52e-05	0.00141	CcSEcCtD
Carteolol—Dysgeusia—Timolol—coronary artery disease	6.52e-05	0.00141	CcSEcCtD
Carteolol—Asthenia—Lovastatin—coronary artery disease	6.51e-05	0.00141	CcSEcCtD
Carteolol—Oedema—Losartan—coronary artery disease	6.48e-05	0.0014	CcSEcCtD
Carteolol—Hypotension—Perindopril—coronary artery disease	6.45e-05	0.0014	CcSEcCtD
Carteolol—Insomnia—Captopril—coronary artery disease	6.43e-05	0.00139	CcSEcCtD
Carteolol—Asthenia—Ezetimibe—coronary artery disease	6.38e-05	0.00138	CcSEcCtD
Carteolol—Shock—Losartan—coronary artery disease	6.37e-05	0.00138	CcSEcCtD
Carteolol—Nausea—Rosuvastatin—coronary artery disease	6.36e-05	0.00138	CcSEcCtD
Carteolol—Dyspnoea—Captopril—coronary artery disease	6.34e-05	0.00137	CcSEcCtD
Carteolol—Arrhythmia—Lisinopril—coronary artery disease	6.33e-05	0.00137	CcSEcCtD
Carteolol—Hypotension—Furosemide—coronary artery disease	6.27e-05	0.00136	CcSEcCtD
Carteolol—Vision blurred—Timolol—coronary artery disease	6.27e-05	0.00136	CcSEcCtD
Carteolol—Hypersensitivity—Simvastatin—coronary artery disease	6.25e-05	0.00135	CcSEcCtD
Carteolol—Insomnia—Perindopril—coronary artery disease	6.25e-05	0.00135	CcSEcCtD
Carteolol—Asthenia—Eplerenone—coronary artery disease	6.25e-05	0.00135	CcSEcCtD
Carteolol—Nausea—Acetylsalicylic acid—coronary artery disease	6.17e-05	0.00134	CcSEcCtD
Carteolol—Dyspnoea—Perindopril—coronary artery disease	6.16e-05	0.00133	CcSEcCtD
Carteolol—Dizziness—Fenofibrate—coronary artery disease	6.14e-05	0.00133	CcSEcCtD
Carteolol—Syncope—Ramipril—coronary artery disease	6.1e-05	0.00132	CcSEcCtD
Carteolol—Asthenia—Simvastatin—coronary artery disease	6.09e-05	0.00132	CcSEcCtD
Carteolol—Hypotension—Losartan—coronary artery disease	6.05e-05	0.00131	CcSEcCtD
Carteolol—Dysgeusia—Lisinopril—coronary artery disease	6.05e-05	0.00131	CcSEcCtD
Carteolol—Dizziness—Clopidogrel—coronary artery disease	6.04e-05	0.00131	CcSEcCtD
Carteolol—Palpitations—Ramipril—coronary artery disease	6.02e-05	0.0013	CcSEcCtD
Carteolol—Dizziness—Lovastatin—coronary artery disease	6e-05	0.0013	CcSEcCtD
Carteolol—Loss of consciousness—Ramipril—coronary artery disease	5.98e-05	0.0013	CcSEcCtD
Carteolol—Syncope—Timolol—coronary artery disease	5.97e-05	0.00129	CcSEcCtD
Carteolol—Hypersensitivity—Valsartan—coronary artery disease	5.9e-05	0.00128	CcSEcCtD
Carteolol—Dizziness—Ezetimibe—coronary artery disease	5.88e-05	0.00128	CcSEcCtD
Carteolol—Palpitations—Timolol—coronary artery disease	5.88e-05	0.00127	CcSEcCtD
Carteolol—Insomnia—Losartan—coronary artery disease	5.86e-05	0.00127	CcSEcCtD
Carteolol—Loss of consciousness—Timolol—coronary artery disease	5.85e-05	0.00127	CcSEcCtD
Carteolol—Headache—Fenofibrate—coronary artery disease	5.82e-05	0.00126	CcSEcCtD
Carteolol—Vision blurred—Lisinopril—coronary artery disease	5.82e-05	0.00126	CcSEcCtD
Carteolol—Dyspnoea—Losartan—coronary artery disease	5.78e-05	0.00125	CcSEcCtD
Carteolol—Dizziness—Eplerenone—coronary artery disease	5.76e-05	0.00125	CcSEcCtD
Carteolol—Asthenia—Valsartan—coronary artery disease	5.75e-05	0.00125	CcSEcCtD
Carteolol—Hypersensitivity—Niacin—coronary artery disease	5.74e-05	0.00124	CcSEcCtD
Carteolol—Asthenia—Olmesartan—coronary artery disease	5.72e-05	0.00124	CcSEcCtD
Carteolol—Headache—Clopidogrel—coronary artery disease	5.72e-05	0.00124	CcSEcCtD
Carteolol—Headache—Lovastatin—coronary artery disease	5.68e-05	0.00123	CcSEcCtD
Carteolol—Hypersensitivity—Pravastatin—coronary artery disease	5.65e-05	0.00122	CcSEcCtD
Carteolol—Dizziness—Simvastatin—coronary artery disease	5.61e-05	0.00122	CcSEcCtD
Carteolol—Asthenia—Niacin—coronary artery disease	5.59e-05	0.00121	CcSEcCtD
Carteolol—Headache—Ezetimibe—coronary artery disease	5.57e-05	0.00121	CcSEcCtD
Carteolol—Oedema—Ramipril—coronary artery disease	5.56e-05	0.0012	CcSEcCtD
Carteolol—Syncope—Lisinopril—coronary artery disease	5.54e-05	0.0012	CcSEcCtD
Carteolol—Nausea—Fenofibrate—coronary artery disease	5.52e-05	0.0012	CcSEcCtD
Carteolol—Asthenia—Pravastatin—coronary artery disease	5.5e-05	0.00119	CcSEcCtD
Carteolol—Hypersensitivity—Trandolapril—coronary artery disease	5.49e-05	0.00119	CcSEcCtD
Carteolol—Shock—Ramipril—coronary artery disease	5.47e-05	0.00118	CcSEcCtD
Carteolol—Hypersensitivity—Enalapril—coronary artery disease	5.46e-05	0.00118	CcSEcCtD
Carteolol—Palpitations—Lisinopril—coronary artery disease	5.46e-05	0.00118	CcSEcCtD
Carteolol—Headache—Eplerenone—coronary artery disease	5.45e-05	0.00118	CcSEcCtD
Carteolol—Oedema—Timolol—coronary artery disease	5.43e-05	0.00118	CcSEcCtD
Carteolol—Loss of consciousness—Lisinopril—coronary artery disease	5.43e-05	0.00118	CcSEcCtD
Carteolol—Nausea—Clopidogrel—coronary artery disease	5.42e-05	0.00118	CcSEcCtD
Carteolol—Hypersensitivity—Telmisartan—coronary artery disease	5.39e-05	0.00117	CcSEcCtD
Carteolol—Nausea—Lovastatin—coronary artery disease	5.39e-05	0.00117	CcSEcCtD
Carteolol—Asthenia—Trandolapril—coronary artery disease	5.34e-05	0.00116	CcSEcCtD
Carteolol—Shock—Timolol—coronary artery disease	5.34e-05	0.00116	CcSEcCtD
Carteolol—Asthenia—Enalapril—coronary artery disease	5.32e-05	0.00115	CcSEcCtD
Carteolol—Headache—Simvastatin—coronary artery disease	5.31e-05	0.00115	CcSEcCtD
Carteolol—Dizziness—Valsartan—coronary artery disease	5.3e-05	0.00115	CcSEcCtD
Carteolol—Nausea—Ezetimibe—coronary artery disease	5.28e-05	0.00115	CcSEcCtD
Carteolol—Dizziness—Olmesartan—coronary artery disease	5.27e-05	0.00114	CcSEcCtD
Carteolol—Asthenia—Telmisartan—coronary artery disease	5.25e-05	0.00114	CcSEcCtD
Carteolol—Hypotension—Ramipril—coronary artery disease	5.19e-05	0.00113	CcSEcCtD
Carteolol—Nausea—Eplerenone—coronary artery disease	5.17e-05	0.00112	CcSEcCtD
Carteolol—Dizziness—Niacin—coronary artery disease	5.15e-05	0.00112	CcSEcCtD
Carteolol—Asthenia—Captopril—coronary artery disease	5.1e-05	0.00111	CcSEcCtD
Carteolol—Hypotension—Timolol—coronary artery disease	5.07e-05	0.0011	CcSEcCtD
Carteolol—Dizziness—Pravastatin—coronary artery disease	5.07e-05	0.0011	CcSEcCtD
Carteolol—Nausea—Simvastatin—coronary artery disease	5.04e-05	0.00109	CcSEcCtD
Carteolol—Oedema—Lisinopril—coronary artery disease	5.04e-05	0.00109	CcSEcCtD
Carteolol—Insomnia—Ramipril—coronary artery disease	5.02e-05	0.00109	CcSEcCtD
Carteolol—Headache—Valsartan—coronary artery disease	5.02e-05	0.00109	CcSEcCtD
Carteolol—Headache—Olmesartan—coronary artery disease	4.99e-05	0.00108	CcSEcCtD
Carteolol—Shock—Lisinopril—coronary artery disease	4.96e-05	0.00107	CcSEcCtD
Carteolol—Asthenia—Perindopril—coronary artery disease	4.96e-05	0.00107	CcSEcCtD
Carteolol—Dyspnoea—Ramipril—coronary artery disease	4.95e-05	0.00107	CcSEcCtD
Carteolol—Hypersensitivity—Furosemide—coronary artery disease	4.95e-05	0.00107	CcSEcCtD
Carteolol—Dizziness—Trandolapril—coronary artery disease	4.92e-05	0.00107	CcSEcCtD
Carteolol—Insomnia—Timolol—coronary artery disease	4.91e-05	0.00106	CcSEcCtD
Carteolol—Dizziness—Enalapril—coronary artery disease	4.9e-05	0.00106	CcSEcCtD
Carteolol—Headache—Niacin—coronary artery disease	4.88e-05	0.00106	CcSEcCtD
Carteolol—Dyspnoea—Timolol—coronary artery disease	4.84e-05	0.00105	CcSEcCtD
Carteolol—Dizziness—Telmisartan—coronary artery disease	4.84e-05	0.00105	CcSEcCtD
Carteolol—Asthenia—Furosemide—coronary artery disease	4.82e-05	0.00104	CcSEcCtD
Carteolol—Headache—Pravastatin—coronary artery disease	4.8e-05	0.00104	CcSEcCtD
Carteolol—Hypersensitivity—Losartan—coronary artery disease	4.77e-05	0.00103	CcSEcCtD
Carteolol—Nausea—Valsartan—coronary artery disease	4.76e-05	0.00103	CcSEcCtD
Carteolol—Nausea—Olmesartan—coronary artery disease	4.74e-05	0.00103	CcSEcCtD
Carteolol—Hypotension—Lisinopril—coronary artery disease	4.71e-05	0.00102	CcSEcCtD
Carteolol—Dizziness—Captopril—coronary artery disease	4.7e-05	0.00102	CcSEcCtD
Carteolol—Headache—Trandolapril—coronary artery disease	4.67e-05	0.00101	CcSEcCtD
Carteolol—Asthenia—Losartan—coronary artery disease	4.65e-05	0.00101	CcSEcCtD
Carteolol—Headache—Enalapril—coronary artery disease	4.65e-05	0.00101	CcSEcCtD
Carteolol—Nausea—Niacin—coronary artery disease	4.63e-05	0.001	CcSEcCtD
Carteolol—Headache—Telmisartan—coronary artery disease	4.58e-05	0.000994	CcSEcCtD
Carteolol—Dizziness—Perindopril—coronary artery disease	4.57e-05	0.00099	CcSEcCtD
Carteolol—Insomnia—Lisinopril—coronary artery disease	4.56e-05	0.000988	CcSEcCtD
Carteolol—Nausea—Pravastatin—coronary artery disease	4.56e-05	0.000987	CcSEcCtD
Carteolol—Dyspnoea—Lisinopril—coronary artery disease	4.49e-05	0.000974	CcSEcCtD
Carteolol—Headache—Captopril—coronary artery disease	4.46e-05	0.000966	CcSEcCtD
Carteolol—Dizziness—Furosemide—coronary artery disease	4.44e-05	0.000963	CcSEcCtD
Carteolol—Nausea—Trandolapril—coronary artery disease	4.42e-05	0.000959	CcSEcCtD
Carteolol—Nausea—Enalapril—coronary artery disease	4.41e-05	0.000955	CcSEcCtD
Carteolol—Nausea—Telmisartan—coronary artery disease	4.35e-05	0.000942	CcSEcCtD
Carteolol—Headache—Perindopril—coronary artery disease	4.33e-05	0.000938	CcSEcCtD
Carteolol—Dizziness—Losartan—coronary artery disease	4.28e-05	0.000929	CcSEcCtD
Carteolol—Propranolol—ADRB1—coronary artery disease	4.27e-05	0.0264	CrCbGaD
Carteolol—Nausea—Captopril—coronary artery disease	4.23e-05	0.000916	CcSEcCtD
Carteolol—Headache—Furosemide—coronary artery disease	4.21e-05	0.000912	CcSEcCtD
Carteolol—Nausea—Perindopril—coronary artery disease	4.1e-05	0.000889	CcSEcCtD
Carteolol—Hypersensitivity—Ramipril—coronary artery disease	4.09e-05	0.000887	CcSEcCtD
Carteolol—Headache—Losartan—coronary artery disease	4.06e-05	0.00088	CcSEcCtD
Carteolol—Hypersensitivity—Timolol—coronary artery disease	4e-05	0.000867	CcSEcCtD
Carteolol—Nausea—Furosemide—coronary artery disease	3.99e-05	0.000865	CcSEcCtD
Carteolol—Asthenia—Ramipril—coronary artery disease	3.99e-05	0.000864	CcSEcCtD
Carteolol—Asthenia—Timolol—coronary artery disease	3.9e-05	0.000845	CcSEcCtD
Carteolol—Nausea—Losartan—coronary artery disease	3.85e-05	0.000834	CcSEcCtD
Carteolol—Hypersensitivity—Lisinopril—coronary artery disease	3.71e-05	0.000805	CcSEcCtD
Carteolol—Dizziness—Ramipril—coronary artery disease	3.67e-05	0.000796	CcSEcCtD
Carteolol—Asthenia—Lisinopril—coronary artery disease	3.61e-05	0.000784	CcSEcCtD
Carteolol—Propranolol—ADRB2—coronary artery disease	3.59e-05	0.0222	CrCbGaD
Carteolol—Dizziness—Timolol—coronary artery disease	3.59e-05	0.000778	CcSEcCtD
Carteolol—Headache—Ramipril—coronary artery disease	3.48e-05	0.000754	CcSEcCtD
Carteolol—Headache—Timolol—coronary artery disease	3.4e-05	0.000738	CcSEcCtD
Carteolol—Dizziness—Lisinopril—coronary artery disease	3.33e-05	0.000722	CcSEcCtD
Carteolol—Nausea—Ramipril—coronary artery disease	3.3e-05	0.000715	CcSEcCtD
Carteolol—Nausea—Timolol—coronary artery disease	3.23e-05	0.000699	CcSEcCtD
Carteolol—Headache—Lisinopril—coronary artery disease	3.16e-05	0.000684	CcSEcCtD
Carteolol—Propranolol—CYP2C19—coronary artery disease	3.09e-05	0.0191	CrCbGaD
Carteolol—Nausea—Lisinopril—coronary artery disease	2.99e-05	0.000649	CcSEcCtD
Carteolol—ADRB2—Signaling by GPCR—C3—coronary artery disease	4.47e-06	0.000256	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDNRB—coronary artery disease	4.44e-06	0.000254	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PSMA6—coronary artery disease	4.43e-06	0.000253	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PSMB5—coronary artery disease	4.43e-06	0.000253	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—F2—coronary artery disease	4.42e-06	0.000253	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA4—coronary artery disease	4.41e-06	0.000252	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—THBS1—coronary artery disease	4.37e-06	0.00025	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AGT—coronary artery disease	4.34e-06	0.000248	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PSMA6—coronary artery disease	4.33e-06	0.000248	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PSMB5—coronary artery disease	4.33e-06	0.000248	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—F2—coronary artery disease	4.32e-06	0.000247	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDNRA—coronary artery disease	4.29e-06	0.000245	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CYBA—coronary artery disease	4.27e-06	0.000244	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PDHA1—coronary artery disease	4.26e-06	0.000244	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCLM—coronary artery disease	4.26e-06	0.000244	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—DUSP6—coronary artery disease	4.25e-06	0.000243	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AGT—coronary artery disease	4.25e-06	0.000243	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDNRA—coronary artery disease	4.19e-06	0.00024	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLAT—coronary artery disease	4.18e-06	0.000239	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CYBA—coronary artery disease	4.17e-06	0.000239	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ADRB1—coronary artery disease	4.17e-06	0.000239	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—DUSP6—coronary artery disease	4.16e-06	0.000238	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—TXNRD1—coronary artery disease	4.13e-06	0.000236	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP11B2—coronary artery disease	4.13e-06	0.000236	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLAT—coronary artery disease	4.09e-06	0.000234	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC22A3—coronary artery disease	4.06e-06	0.000233	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—BDKRB2—coronary artery disease	4.03e-06	0.000231	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL12—coronary artery disease	4.03e-06	0.000231	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—POMC—coronary artery disease	4.02e-06	0.00023	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—F2—coronary artery disease	4.01e-06	0.000229	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ARNTL—coronary artery disease	4e-06	0.000229	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HADH—coronary artery disease	4e-06	0.000229	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6ST—coronary artery disease	3.99e-06	0.000229	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JUNB—coronary artery disease	3.95e-06	0.000226	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—BDKRB2—coronary artery disease	3.94e-06	0.000225	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL12—coronary artery disease	3.94e-06	0.000225	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLCB1—coronary artery disease	3.94e-06	0.000225	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—POMC—coronary artery disease	3.94e-06	0.000225	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—F2—coronary artery disease	3.92e-06	0.000224	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6ST—coronary artery disease	3.91e-06	0.000224	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JUNB—coronary artery disease	3.87e-06	0.000221	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR7—coronary artery disease	3.86e-06	0.000221	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLCB1—coronary artery disease	3.85e-06	0.000221	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	3.8e-06	0.000217	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA2—coronary artery disease	3.8e-06	0.000217	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX2—coronary artery disease	3.8e-06	0.000217	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR7—coronary artery disease	3.77e-06	0.000216	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCG5—coronary artery disease	3.75e-06	0.000215	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SULT1A1—coronary artery disease	3.75e-06	0.000215	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HK1—coronary artery disease	3.75e-06	0.000215	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX4—coronary artery disease	3.75e-06	0.000215	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HADHA—coronary artery disease	3.71e-06	0.000212	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	3.68e-06	0.00021	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KNG1—coronary artery disease	3.67e-06	0.00021	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTA1—coronary artery disease	3.66e-06	0.00021	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—POMC—coronary artery disease	3.65e-06	0.000209	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	3.65e-06	0.000209	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	3.64e-06	0.000208	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPA—coronary artery disease	3.62e-06	0.000207	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	3.6e-06	0.000206	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	3.59e-06	0.000205	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	3.57e-06	0.000205	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	3.57e-06	0.000204	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	3.57e-06	0.000204	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	3.56e-06	0.000204	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	3.56e-06	0.000204	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	3.56e-06	0.000204	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PLG—coronary artery disease	3.55e-06	0.000203	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLCB3—coronary artery disease	3.51e-06	0.000201	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	3.5e-06	0.0002	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	3.49e-06	0.000199	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	3.48e-06	0.000199	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PLG—coronary artery disease	3.47e-06	0.000199	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA5—coronary artery disease	3.47e-06	0.000199	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	3.46e-06	0.000198	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	3.41e-06	0.000195	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	3.41e-06	0.000195	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—P4HB—coronary artery disease	3.41e-06	0.000195	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	3.4e-06	0.000195	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	3.4e-06	0.000194	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	3.36e-06	0.000192	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	3.34e-06	0.000191	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	3.34e-06	0.000191	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	3.34e-06	0.000191	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	3.33e-06	0.000191	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	3.32e-06	0.00019	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	3.32e-06	0.00019	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	3.32e-06	0.00019	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	3.29e-06	0.000188	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	3.25e-06	0.000186	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	3.25e-06	0.000186	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	3.25e-06	0.000186	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	3.25e-06	0.000186	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	3.18e-06	0.000182	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	3.18e-06	0.000182	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—VCAN—coronary artery disease	3.15e-06	0.00018	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	3.14e-06	0.00018	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALDOA—coronary artery disease	3.13e-06	0.000179	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	3.11e-06	0.000178	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	3.1e-06	0.000177	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	3.09e-06	0.000177	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	3.07e-06	0.000176	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	3.07e-06	0.000175	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	3.04e-06	0.000174	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—DCN—coronary artery disease	3.04e-06	0.000174	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	3.03e-06	0.000173	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	3.02e-06	0.000173	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	3.02e-06	0.000173	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	3.02e-06	0.000173	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	3e-06	0.000172	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	3e-06	0.000171	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	2.97e-06	0.00017	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	2.97e-06	0.00017	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	2.95e-06	0.000169	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	2.95e-06	0.000169	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALDH2—coronary artery disease	2.95e-06	0.000169	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	2.93e-06	0.000168	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	2.91e-06	0.000166	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	2.91e-06	0.000166	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	2.89e-06	0.000166	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CYP2C19—coronary artery disease	2.88e-06	0.000165	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	2.88e-06	0.000165	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LIPC—coronary artery disease	2.88e-06	0.000165	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HBA1—coronary artery disease	2.88e-06	0.000165	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOC3—coronary artery disease	2.86e-06	0.000164	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LDLR—coronary artery disease	2.84e-06	0.000163	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	2.83e-06	0.000162	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	2.83e-06	0.000162	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	2.81e-06	0.000161	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SLC9A1—coronary artery disease	2.81e-06	0.000161	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTT1—coronary artery disease	2.81e-06	0.000161	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CETP—coronary artery disease	2.78e-06	0.000159	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GCLC—coronary artery disease	2.78e-06	0.000159	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	2.76e-06	0.000158	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	2.76e-06	0.000158	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	2.75e-06	0.000157	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—SDC1—coronary artery disease	2.74e-06	0.000157	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	2.7e-06	0.000155	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	2.7e-06	0.000155	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—C3—coronary artery disease	2.7e-06	0.000154	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	2.64e-06	0.000151	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—C3—coronary artery disease	2.64e-06	0.000151	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PSMA6—coronary artery disease	2.59e-06	0.000148	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PSMB5—coronary artery disease	2.59e-06	0.000148	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	2.57e-06	0.000147	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	2.56e-06	0.000147	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CTGF—coronary artery disease	2.53e-06	0.000145	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	2.52e-06	0.000144	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	2.51e-06	0.000144	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	2.51e-06	0.000144	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMGCR—coronary artery disease	2.51e-06	0.000144	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GOT2—coronary artery disease	2.51e-06	0.000144	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	2.51e-06	0.000144	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	2.48e-06	0.000142	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	2.46e-06	0.000141	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	2.46e-06	0.000141	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	2.46e-06	0.000141	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	2.44e-06	0.00014	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	2.43e-06	0.000139	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	2.41e-06	0.000138	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	2.4e-06	0.000137	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	2.39e-06	0.000137	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	2.37e-06	0.000136	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—F2—coronary artery disease	2.37e-06	0.000136	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	2.36e-06	0.000135	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	2.35e-06	0.000134	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	2.34e-06	0.000134	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—F2—coronary artery disease	2.32e-06	0.000133	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	2.32e-06	0.000133	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.31e-06	0.000132	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	2.31e-06	0.000132	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	2.29e-06	0.000131	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	2.27e-06	0.00013	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.24e-06	0.000128	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	2.22e-06	0.000127	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	2.18e-06	0.000124	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GGT1—coronary artery disease	2.17e-06	0.000124	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GOT1—coronary artery disease	2.17e-06	0.000124	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	2.16e-06	0.000123	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	2.16e-06	0.000123	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	2.13e-06	0.000122	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	2.11e-06	0.000121	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	2.11e-06	0.000121	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	2.11e-06	0.000121	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	2.11e-06	0.00012	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	2.08e-06	0.000119	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	2.07e-06	0.000118	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	2.07e-06	0.000118	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	2.06e-06	0.000118	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	2.03e-06	0.000116	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	2.02e-06	0.000116	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.97e-06	0.000113	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	1.97e-06	0.000113	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTP1—coronary artery disease	1.95e-06	0.000111	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.93e-06	0.00011	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	1.93e-06	0.00011	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	1.93e-06	0.00011	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—HMOX1—coronary artery disease	1.92e-06	0.00011	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	1.91e-06	0.000109	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CAT—coronary artery disease	1.89e-06	0.000108	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	1.88e-06	0.000108	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	1.87e-06	0.000107	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	1.84e-06	0.000105	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOB—coronary artery disease	1.84e-06	0.000105	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	1.83e-06	0.000105	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	1.79e-06	0.000103	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	1.79e-06	0.000102	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GSTM1—coronary artery disease	1.79e-06	0.000102	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—LPL—coronary artery disease	1.76e-06	0.0001	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	1.75e-06	0.0001	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—GPX1—coronary artery disease	1.71e-06	9.8e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	1.67e-06	9.55e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—CD36—coronary artery disease	1.67e-06	9.55e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.65e-06	9.43e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	1.63e-06	9.34e-05	CbGpPWpGaD
Carteolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.61e-06	9.23e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.6e-06	9.14e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.59e-06	9.08e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.58e-06	9.05e-05	CbGpPWpGaD
Carteolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	1.58e-06	9.03e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	1.56e-06	8.94e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.56e-06	8.9e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	1.55e-06	8.89e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	1.52e-06	8.7e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.51e-06	8.64e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AGT—coronary artery disease	1.5e-06	8.59e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	1.48e-06	8.45e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOE—coronary artery disease	1.47e-06	8.42e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.46e-06	8.38e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—APOA1—coronary artery disease	1.45e-06	8.32e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	1.43e-06	8.2e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.36e-06	7.76e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	1.33e-06	7.59e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PPARG—coronary artery disease	1.28e-06	7.33e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—POMC—coronary artery disease	1.26e-06	7.23e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.24e-06	7.12e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.22e-06	6.98e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.22e-06	6.97e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.19e-06	6.83e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—ALB—coronary artery disease	1.15e-06	6.6e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—NOS3—coronary artery disease	1.1e-06	6.31e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	1.06e-06	6.06e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	1.04e-06	5.93e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.01e-06	5.77e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	9.38e-07	5.37e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	9.17e-07	5.25e-05	CbGpPWpGaD
Carteolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	8.65e-07	4.95e-05	CbGpPWpGaD
Carteolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	8.46e-07	4.84e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—PIK3CA—coronary artery disease	6.2e-07	3.55e-05	CbGpPWpGaD
Carteolol—CYP2D6—Metabolism—AKT1—coronary artery disease	5.07e-07	2.9e-05	CbGpPWpGaD
